涂梦欣, 黄梅, 张彦琦, 陈虹雨, 尚雪祎, 李金锦, 徐旖旎, 沈祥春, 张彦燕. 松油烯-4-醇通过改善线粒体动力学抑制血管平滑肌细胞钙化J. 药学学报, 2023, 58(10): 3024-3031. DOI: 10.16438/j.0513-4870.2023-0219
引用本文: 涂梦欣, 黄梅, 张彦琦, 陈虹雨, 尚雪祎, 李金锦, 徐旖旎, 沈祥春, 张彦燕. 松油烯-4-醇通过改善线粒体动力学抑制血管平滑肌细胞钙化J. 药学学报, 2023, 58(10): 3024-3031. DOI: 10.16438/j.0513-4870.2023-0219
TU Meng-xin, HUANG Mei, ZHANG Yan-qi, CHEN Hong-yu, SHANG Xue-yi, LI Jin-jin, XU Yi-ni, SHEN Xiang-chun, ZHANG Yan-yan. Terpine-4-ol on inhibiting vascular smooth muscle cell calcification by improving mitochondrial dynamicsJ. Acta Pharmaceutica Sinica, 2023, 58(10): 3024-3031. DOI: 10.16438/j.0513-4870.2023-0219
Citation: TU Meng-xin, HUANG Mei, ZHANG Yan-qi, CHEN Hong-yu, SHANG Xue-yi, LI Jin-jin, XU Yi-ni, SHEN Xiang-chun, ZHANG Yan-yan. Terpine-4-ol on inhibiting vascular smooth muscle cell calcification by improving mitochondrial dynamicsJ. Acta Pharmaceutica Sinica, 2023, 58(10): 3024-3031. DOI: 10.16438/j.0513-4870.2023-0219

松油烯-4-醇通过改善线粒体动力学抑制血管平滑肌细胞钙化

Terpine-4-ol on inhibiting vascular smooth muscle cell calcification by improving mitochondrial dynamics

  • 摘要: 本研究旨在探讨松油烯-4-醇(terpinen-4-ol, T4O) 对高糖(high glucose, HG) 诱导的血管平滑肌细胞(vascular smooth muscle cell, VSMC) 钙化的作用及机制。研究T4O对HG诱导的VSMC钙质沉积、成骨表型转化及线粒体动力学的作用。采用线粒体动力相关蛋白Drp-1 (dynamin-related protein 1, Drp-1) 抑制剂Mdivi-1分析线粒体动力学和VSMC钙化之间的相关性以及T4O的作用。采用茜素红S染色观察钙盐沉积, 流式细胞术检测细胞内Ca2+含量; Western blot、免疫荧光检测表型转化相关标志物α-平滑肌肌动蛋白(α-smooth muscle actin, α-SMA)、骨形态发生蛋白-2 (bone morphogenetic protein 2, BMP2) 和Runt相关转录因子2 (Runt related transcription factor 2, Runx2) 和线粒体动力学相关标志物线粒体融合蛋白1 (mitofusin 1,MFN1)、线粒体融合蛋白2 (mitofusin 2,MFN2) 和Drp-1 的表达。结果显示, T4O低、高剂量能够不同程度抑制HG诱导的α-SMA、MFN1、MFN2表达水平的下调, 抑制BMP2、Runx2、Drp-1表达水平的上调, 减少细胞内Ca2+含量和钙盐沉积, 有效抑制HG诱导的VSMC钙化和线粒体动力学紊乱。T4O组、Mdivi-1组、T4O+Mdivi-1组能够上调HG诱导的α-SMA、MFN1、MFN2的表达水平, 下调BMP2、Runx2、Drp-1的蛋白表达水平, 抑制钙盐沉积, 且T4O组与T4O+Mdivi-1组上述指标无明显差异。上述研究结果表明, 松油烯-4-醇能够抑制Drp-1的表达水平, 调节线粒体动力学紊乱, 抑制HG诱导的VSMC钙化。

     

    Abstract: The aim of this study was to investigate the role and mechanism of terpinen-4-ol (T4O) on high glucose (HG) -induced calcification in vascular smooth muscle cell (VSMC). To investigate the role of T4O on HG-induced calcium deposition, osteogenic phenotypic transformation and mitochondrial dynamics in VSMC, Mdivi-1, a mitochondrial dynamin-related protein 1 (Drp-1) inhibitor, was used to analyze the correlation between mitochondrial dynamics and VSMC calcification and the role of T4O. Alizarin red S staining was used to observe calcium salt deposition and flow cytometry to detect intracellular Ca2+ content; Western blot and immunofluorescence were used to detect the expression of phenotypic switching-related markers α-smooth muscle actin (α-SMA), bone morphogenetic protein 2 (BMP2) and Runt related transcription factor 2 (Runx2), and mitochondrial dynamics-related markers mitofusin 1 (MFN1), mitofusin 2 (MFN2) and Drp-1. The results showed that low and high doses of T4O could inhibit HG-induced down-regulation of α-SMA, MFN1 and MFN2 expression levels, and up-regulation of BMP2, Runx2 and Drp-1 expression levels, reduce intracellular Ca2+ content and calcium salt deposition, and effectively inhibit HG-induced VSMC calcification and mitochondrial dynamics disorders. The T4O group, Mdivi-1 group and T4O+Mdivi-1 group were able to up-regulate the expression levels of HG-induced α-SMA, MFN1 and MFN2, down-regulate the protein expression levels of BMP2, Runx2 and Drp-1, and inhibit calcium salt deposition, and there was no significant difference between the above indexes in the T4O and T4O+Mdivi-1 groups. The above findings suggest that T4O can inhibit the expression level of Drp-1, regulate the disturbance of mitochondrial dynamics, and suppress HG-induced VSMC calcification.

     

/

返回文章
返回